Answer
Its selected licence is as adjunctive treatment for seizures associated with Lennox-Gastaut syndrome, meaning it is added to an existing treatment plan.
Sources for this answer
- Rufinamide Brown & Burk 200 mg Film-coated Tabletsemc · SmPC Current selected SmPC · Version 1
- Rufinamide Eisai Oral Suspensionemc · SmPC Current selected SmPC · Version 10